Document is current
Any future updates will be listed below
-
Authors
Reddy, Shiva http://orcid.org/0000-0002-4504-0511
Krogvold, Lars
Martin, Charlton
Sun, Kevin Xueying
Martin, Owen
Al-Ani, Aamenah
Dahl-Jørgensen, Knut
-
Funding
Funding for this research was provided by:
Maurice Phyllis Paykel Trust (3713461)
New Zealand Society for the Study of Diabetes (3719136)
- License Information
-
More Information
Article History
Received: 28 April 2020
Accepted: 5 November 2020
First Online: 11 January 2021
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Informed consent for donation and analysis of pancreatic biopsies from DiViD donors were obtained by the DiViD Study Group from the Norwegian Government’s Regional Ethics Committee.
: Ethical approval for conducting this study was granted by the New Zealand Ministry of Health and Disability Ethics Committee (approval number NTX/11/EXP/092/AM02). Approval for biopsy procurement from new-onset type 1 diabetes donors was granted by the Norwegian Government’s Regional Ethics Committee following informed consent. Ethical approval for the analysis of pancreatic sections from deceased nPOD donors was granted to nPOD. Ethical approval for analysis of sections from postmortem pancreas for EADB (ExternalRef removed) was granted by the West of Scotland Research Committee 4 (WoSREC4; 15/WS/0258) to Professors S Richardson and N Morgan, University of Exeter. Therefore, all procedures performed in studies involving human tissue donors were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The content and views expressed in this publication are the responsibility of the authors and do not reflect an official view of nPOD, DiViD and EADB.
